-
Federal
Reporting of adverse drug reactions in randomised controlled trials – a systematic survey
U.S. Department of Health & Human Services —
Background Decisions on treatment are guided, not only by the potential for benefit, but also by the nature and severity of adverse drug reactions. However, some... -
Federal
Pooling, meta-analysis, and the evaluation of drug safety
U.S. Department of Health & Human Services —
Background The "integrated safety report" of the drug registration files submitted to health authorities usually summarizes the rates of adverse events observed for a... -
Federal
Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
U.S. Department of Health & Human Services —
Background We would expect information on adverse drug reactions in randomised clinical trials to be easily retrievable from specific searches of electronic...